[7] Suzuki Y，Iida M，Ito H，et al. Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis：a multicenter，randomized，double-blind，parallel-group study [J]. Intest Res，2016，14(1)：50-59.

    [8] Doherty G，Katsanos KH，Burisch J，et al. European Crohn′s and Colitis Organisation Topical Review on Treatment Withdrawal (′Exit Strategies′) in Inflammatory Bowel Disease [J]. J Crohns Colitis ......